YWY-33660-98268
4 vaccinations
8 coded responses
46 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 140 / NY
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: Dysmenorrhoea, Intermenstrual bleeding — Feeling: Good · Site: PainFree text: Mild menstrual cramping and light spotting mid-cycle (day 13)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Epistaxis — Feeling: GoodFree text: Bloody mucus when blew nose first thing in morning; no additional throughout day. Still some mild menstrual cramps mid-cycle (day 14); no spotting today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: Intermenstrual bleeding — Feeling: GoodFree text: Light menstrual spotting for past two days starting in evenings (after v-safe check-in)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: GoodFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: GoodFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-13
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: GoodFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
- 2021-10-07
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2021-10-08
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-10-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2021-10-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-10-13
Survey response — days 1–6 daily, dose 3MedDRA: Injection site warmth — Feeling: Good · Site: Redness, ItchingFree text: Injection site has been warm for last four days.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2022-01-07
- 2022-04-08
-
2022-09-24
Dose 4 — Pfizer-BioNTech
-
2022-10-08
Survey response — 12 months, dose 3MedDRA: Heart failure with reduced ejection fraction — Feeling: GoodFree text: Heart failure (EF = 45%)MedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-11-05
-
2022-12-24
Health check-in — 3 months, dose 4Feeling: GoodFree text: Dizziness, nauseaAdult check-in · check-in free text available
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-09-24 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Mild menstrual cramping and light spotting mid-cycle (day 13)
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Bloody mucus when blew nose first thing in morning; no additional throughout day. Still some mild menstrual cramps mid-cycle (day 14); no spotting today.
Systemic reaction (other): Light menstrual spotting for past two days starting in evenings (after v-safe check-in)
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Systemic reaction (other): Shortness of breath
Systemic reaction (other): Shortness of breath
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Injection site has been warm for last four days.
Release 12 — 12 months, dose 3
Symptoms: Heart failure (EF = 45%)
Release 12 — 3 months, dose 4
Symptoms: Dizziness, nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heart failure with reduced ejection fraction | · | · | ✓ |
| SRO | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Epistaxis | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Intermenstrual bleeding | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release